FLT3 inhibitor HM43239
Term · Oncology and biomedicine · MLC-T-ONC-013628
A selective, reversible type I inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) with potential antineoplastic activity. Upon administration of FLT3 inhibitor HM43239, it reversibly binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias.
| Identifier | MLC-T-ONC-013628 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | FMS-like tyrosine kinase 3 inhibitor HM43239 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013628",
"term": "FLT3 inhibitor HM43239",
"field": "Oncology and biomedicine",
"definition": "A selective, reversible type I inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) with potential antineoplastic activity. Upon administration of FLT3 inhibitor HM43239, it reversibly binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias.",
"synonyms": [
"FMS-like tyrosine kinase 3 inhibitor HM43239"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/flt3-inhibitor-hm43239/"
}
Record 7,362 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.